Insider · CIK 0001182464

GOEDDEL DAVID V

Reports to the SEC for 12 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001182464

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-29	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, 10% Owner	AAward	+107K sh	—	—	107,400
2025-03-05	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+35.7M sh	$0.70	+$25M	49,313,559
2025-03-05	TNYATenaya Therapeutics, Inc. · Series A Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+35.7M sh	—	—	35,714,284
2025-03-05	TNYATenaya Therapeutics, Inc. · Series B Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+17.9M sh	—	—	17,857,142
2024-10-18	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, 10% Owner	AAward	+34K sh	—	—	34,000
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−134K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−190K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−950K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2.65M sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−90.4K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−11.1M sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−858K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−969K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2.27M sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1.3M sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1.3M sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−100K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−100K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCJ Other	Director, 10% Owner	JOther	+1,000 sh	—	—	1,000
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−78.4K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−24.2K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−19.6K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−24K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−16.8K sh	—	—	0
2024-02-12	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+2.22M sh	$4.50	+$10M	13,599,275
2023-11-16	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+1,460 sh	$0.62	+$906.806	134,180
2023-11-16	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+5,840 sh	$0.62	+$3,627.224	949,862
2023-11-15	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+2,720 sh	$0.71	+$1,918.688	132,720
2023-11-15	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+16.8K sh	$0.71	+$11.9K	944,022
2023-06-09	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, 10% Owner	AAward	+29.5K sh	—	—	29,532
2023-05-10	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+78.4K sh	—	—	78,407
2023-03-10	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+6,779 sh	$2.60	+$17.6K	11,377,053
2023-02-08	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.5M sh	$2.60	+$3.9M	11,370,274
2023-01-31	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+177K sh	$5.00	+$883K	927,231
2023-01-30	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+7,542 sh	$5.00	+$37.7K	750,501
2023-01-23	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+9,900 sh	$5.00	+$49.5K	742,959
2023-01-20	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+500 sh	$5.00	+$2,498	733,059
2023-01-19	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+37.6K sh	$5.00	+$188K	732,559
2023-01-19	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+69.7K sh	$2.50	+$174K	9,870,274
2023-01-18	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+136K sh	$2.52	+$341K	9,800,535
2023-01-17	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+49.5K sh	$2.49	+$123K	9,664,847
2023-01-12	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+5,378 sh	$4.95	+$26.6K	694,920
2023-01-11	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+209K sh	$4.76	+$995K	689,542
2023-01-10	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+100K sh	$4.84	+$485K	480,542
2022-12-12	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+300 sh	$4.98	+$1,493.01	380,472
2022-11-22	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+4,330 sh	$5.00	+$21.6K	380,172
2022-11-21	TNYATenaya Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+9.62M sh	$2.60	+$25M	9,615,384
2022-11-21	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+36K sh	$5.00	+$180K	375,842
2022-11-04	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+35.1K sh	$4.72	+$165K	339,845
2022-11-03	NGM BIOPHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+104K sh	$4.99	+$519K	304,787

Recent filings

Accepted (ET)
May 304
GOEDDEL DAVID V0000950170-25-079947
SEC(opens sec.gov)
Mar 74
GOEDDEL DAVID V0000950170-25-035788
SEC(opens sec.gov)
Oct 214
GOEDDEL DAVID V0000950170-24-116059
SEC(opens sec.gov)
Apr 84
GOEDDEL DAVID V0000950142-24-000999
SEC(opens sec.gov)

Companies

Address

1700 OWENS STREET, SUITE 500

SAN FRANCISCO, CA, 94158